For the Inventor, By the Inventor

Enter assignee name

Bridgewater, NJ, United States of America

Salix Pharmaceuticals, Inc.

USPTO Granted Patents = 63

CIPO Patents = 6

EPO Patents = 18

Trademarks = 13

Forward Citations = 488

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

William Forbes (25 out of 27 patents)

Enoch Bortey (18 out of 19 patents)

Petinka I Vlahova (9 out of 25 patents)

4. Pam Golden (9 out of 9 patents)

5. Donglai Yang (9 out of 13 patents)

6. Karen Sue Gushurst (9 out of 14 patents)

7. Mohammed A Kabir (8 out of 9 patents)

8. Lorin K Johnson (8 out of 19 patents)

9. Jeffrey S Stults (7 out of 35 patents)

10. Stephan D Parent (6 out of 49 patents)

11. Nathan Carl Schultheiss (6 out of 11 patents)

12. Yiduo Wu (6 out of 6 patents)

13. Giuseppe Claudio Viscomi (5 out of 40 patents)

14. Kunal Merchant (5 out of 5 patents)

15. Audrey Shaw (5 out of 5 patents)

Core Competencies:

Hepatic Encephalopathy

Irritable Bowel Syndrome

Rifaximin

Aminosalicylates

Gastric Formulations

Colonic Formulations

Travelers Diarrhea

HIV-Associated Diarrhea

Solid Dispersion Forms

2-Hydroxy-5-Phenylazobenzoic Acid Derivatives

Automatic Injection Device

Colonic Purgative Composition

63 patents: Sort by Forward Citations

1. 12285414 - Methods of treating hepatic encephalopathy (2025-04-29),

2. 11779571 - Methods for treating irritable bowel syndrome (IBS) (2023-10-10),

3. 11660292 - Solid dispersion forms of rifaximin (2023-05-30),

4. 11633384 - Methods of treating hepatic encephalopathy (2023-04-25),

5. 11564912 - Methods for treating irritable bowel syndrome (IBS) (2023-01-31),

6. 11311521 - Solid dispersion forms of rifaximin (2022-04-26),

7. 11129817 - Solid dispersion forms of rifaximin (2021-09-28),

8. 10874647 - Solid dispersion forms of rifaximin (2020-12-29),

9. 10765667 - Methods for treating irritable bowel syndrome (IBS) (2020-09-08),

10. 10709694 - Methods of treating hepatic encephalopathy (2020-07-14),

11. 10493064 - IBS microbiota and uses thereof (2019-12-03),

12. 10456384 - Methods for treating irritable bowel syndrome (IBS) (2019-10-29),

13. 10335397 - Methods of treating hepatic encephalopathy (2019-07-02),

14. 10328088 - Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome (2019-06-25),

15. 10314828 - Methods of treating hepatic encephalopathy (2019-06-11),

Salix Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets prescription pharmaceutical products for the prevention and treatment of gastrointestinal disorders. With a focus on improving patient care and addressing unmet medical needs, Salix specializes in innovative therapies that target various areas of gastroenterology, including inflammatory bowel disease, hepatic encephalopathy, and irritable bowel syndrome.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

63 Patents

#10 in Bridgewater, NJ

#241 in New Jersey

#5,528 in US

#11,195 in the World

Bridgewater, NJ, United States of America

Salix Pharmaceuticals, Inc.

Forward Citations = 488

49 inventors:

William Forbes (25 out of 27 patents)

Enoch Bortey (18 out of 19 patents)

Petinka I Vlahova (9 out of 25 patents)

4. Pam Golden (9 out of 9 patents)

5. Donglai Yang (9 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…